Loading insider details...
Beta
Latest Form 4 (Jul 17, 2026): Disposition to Issuer of 40,000 CPRX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 17, 2026 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Disposition to Issuer | 40,000 | n/a |
| Jun 12, 2026 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 5,000 | n/a |
| Jan 21, 2026 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 16,833 | n/a |
| Nov 25, 2025 | CATALYST PHARMACEUTICALS, INC. (CPRX) | Grant/Award | 18,115 | n/a |
| Aug 13, 2025 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/Award | 40,400 | n/a |
| Jun 12, 2025 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 31,000 | n/a |
| Jun 17, 2024 | Xilio Therapeutics, Inc. (XLO) | Grant/Award | 25,000 | n/a |